The academy conducted the survey with Gilead Sciences HIV Medical Affairs, polling 409 PrEP users and 188 prescribers between April 21 and May 15.
Four survey findings:
1. Of respondents who stopped taking PrEP, 85 percent said they were not engaged in behaviors that put them at risk for HIV.
2. Only 11 respondents said an outside factor — such as losing insurance coverage — prevented them from getting the medication.
3. Eighty-nine percent of providers did not recommend patients change their PrEP routines during shelter-in-place.
4. Forty-seven percent of providers said some of their patients elected to stop using PrEP during shelter-in-place.
The academy presented survey data June 8 at the virtual International AIDS Conference and shared its findings with Becker’s via email.
More articles on infection control:
Advocate Aurora leaders told oncology staff not to wear masks in March, nurse says
American College of Physicians: Best practice tips when using masks to prevent COVID-19
More than 5,000 hospital-acquired COVID-19 cases reported since mid-May, CDC says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.